Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Bullboard Posts
Post by RetiringYoungon Dec 08, 2017 10:32am
165 Views
Post# 27117030

News out

News outIncludes two interesting items:

"Demonstrating confidence in the company's direction, many of Imagin's investors have exercised 12-cent and 15-cent warrants, generating over $1-million of capital. The support of these shareholders places the company in a stronger financial position heading into 2018 and the start of the study."

I'm not sure how investors exercising warrants for a 50+% return is showing support, did we expect them to let them expire?

"Imagin is also reporting that the recent sale of 75,000 shares by a director to support the company by exercising warrants was erroneously recorded on an "insider trading" report as 775,000 shares. This report has been corrected."

Not sure how this happens but it's a shame since it could cause investors to see re non-confidence.

Bullboard Posts